CHOU2 PHARMA Partners with Ethos Discovery to Study Potential New Therapy for Canine Idiopathic Epilepsy

NARBERTH, Pa., Jan. 27, 2025 /PRNewswire/ — Chou2 Pharma LLC, a company focused on advancing the therapeutic use of cannabinoid molecules in veterinary medicine, is pleased to announce that the company has initiated a new study in partnership with Ethos Discovery to evaluate…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.